Literature DB >> 28551065

Role of selective intra-arterial embolization in benign liver tumors.

M D Ferrer Puchol1, C La Parra Casado2, A Cervera Araez2, R Sala López3, E Esteban Hernández2, A Cremades Mira4, R Ramiro Gandia2.   

Abstract

OBJECTIVE: To present cases of symptomatic benign liver tumors diagnosed and treated with intra-arterial embolization before surgery.
MATERIAL AND METHODS: We present the cases of 7 patients diagnosed with symptomatic benign liver tumors that required treatment: 1 focal nodular hyperplasia, 2 giant cavernous hemangiomas, 1 hepatic adenomatosis, and 3 hepatic adenomas. Once the feeding arteries were identified, tumors were embolized with polyvinyl alcohol particles (500μm-700μm) and then the feeding artery was plugged with coils if there was an arterial pedicle to ensure the total vascular exclusion of the tumor. The surgical intervention took place 4 to 7 days after embolization.
RESULTS: All 7 patients were women (age range, 23-74 years); presurgical intra-arterial embolization was done in 6. In 1 patient with adenomatosis, embolization was done to control intraparenchymal hepatic hemorrhage. In the 6 patients who underwent surgery, the tumor was completely excised and no intraoperative bleeding events or postoperative complications occurred.
CONCLUSIONS: Provided there is a consensus among the multidisciplinary team, embolization is a useful option in the perioperative management of giant and/or symptomatic benign liver tumors.
Copyright © 2017 SERAM. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Arterial embolization; Embolización arterial; Embolización terapéutica; Liver tumor; Therapeutic embolization; Tratamiento; Treatment; Tumor hepático

Mesh:

Year:  2017        PMID: 28551065     DOI: 10.1016/j.rx.2017.04.007

Source DB:  PubMed          Journal:  Radiologia        ISSN: 0033-8338


  1 in total

1.  Massive hepatic adenoma response to bland embolization: A case study.

Authors:  Margaret A Sinkler; Michael Bosley
Journal:  Radiol Case Rep       Date:  2018-10-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.